Ataque cerebral agudo isquémico

Autores:: Franco Garcia, Samir
Barreiro Pinto, Belis

Tipo de recurso:: Article of journal

Fecha de publicación:: 2020

Institución:: Universidad de Cartagena

Repositorio:: Repositorio Universidad de Cartagena

Idioma:: spa

id	UCART2_3cb6467b52e12867c39cee3716f17331
oai_identifier_str	oai:repositorio.unicartagena.edu.co:11227/13359
network_acronym_str	UCART2
network_name_str	Repositorio Universidad de Cartagena
repository_id_str
dc.title.spa.fl_str_mv	Ataque cerebral agudo isquémico
dc.title.translated.eng.fl_str_mv	Ataque cerebral agudo isquémico
title	Ataque cerebral agudo isquémico
spellingShingle	Ataque cerebral agudo isquémico Ataque. Cerebrovascular. Isquémico. Agudo. Manejo.
title_short	Ataque cerebral agudo isquémico
title_full	Ataque cerebral agudo isquémico
title_fullStr	Ataque cerebral agudo isquémico
title_full_unstemmed	Ataque cerebral agudo isquémico
title_sort	Ataque cerebral agudo isquémico
dc.creator.fl_str_mv	Franco Garcia, Samir Barreiro Pinto, Belis
dc.contributor.author.spa.fl_str_mv	Franco Garcia, Samir Barreiro Pinto, Belis
dc.subject.spa.fl_str_mv	Ataque. Cerebrovascular. Isquémico. Agudo. Manejo.
topic	Ataque. Cerebrovascular. Isquémico. Agudo. Manejo.
publishDate	2020
dc.date.accessioned.none.fl_str_mv	2020-12-22 00:00:00
dc.date.available.none.fl_str_mv	2020-12-22 00:00:00
dc.date.issued.none.fl_str_mv	2020-12-22
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	2215-7840
dc.identifier.uri.none.fl_str_mv	https://hdl.handle.net/11227/13359
dc.identifier.doi.none.fl_str_mv	10.32997/rcb-2010-3091
dc.identifier.eissn.none.fl_str_mv	2389-7252
dc.identifier.url.none.fl_str_mv	https://doi.org/10.32997/rcb-2010-3091
identifier_str_mv	2215-7840 10.32997/rcb-2010-3091 2389-7252
url	https://hdl.handle.net/11227/13359 https://doi.org/10.32997/rcb-2010-3091
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Ciencias Biomédicas
dc.relation.bitstream.none.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3091/2619
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2010
dc.relation.citationendpage.none.fl_str_mv	225
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationstartpage.none.fl_str_mv	217
dc.relation.citationvolume.spa.fl_str_mv	1
dc.relation.references.spa.fl_str_mv	Scott K, Chalela J, et al. Ischemic cerebrovascular disease: Clinical neurology of the Older Adult, 2nd Edition, Chapter 17. 2008 Thom, T. Haase, N. Rosamond, W. et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113: 85 - 95. Finley C, Wijman, Ch. Management of acute ischemic Stroke. Neurol Clin 26 (2008) 345–371. Saposnik G, Del Brutto O. Stroke in South America. A systematic review of incidence, prevalence, and stroke subtypes. Stroke 2003; 34:2103-8. The Publications Committee for the Trial of ORG 10172 in acute Stroke treatment (TOAST) investigators: Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279:1265 – 1272 Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol. 2006; 5: 323 - 331. Albers, G. Transient ischemic attack —Proposal for a new definition. N Engl J Med, 2002: 347 (21): 1713 – 1716. English, Joey. En: Harrison’s principles of internal medicine seventeenth edition, chapter 364. 2008. Guidelines for management of ischaemic Stroke and Transient ischaemic attack 2008. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovas Dis 2008; 25: 457-507. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activatorfor acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587. Stroke Unit Trialists’ Collaboration: A systematic review of the randomised trials of organised impatient (stroke unit) care after stroke. BMJ 1997; 314: 1151 – 1159. IMS investigators: The Interventional Management of Stroke (IMS) II Study. Stroke 2007; 38: 2127–2135. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339: 1415-1425. European Carotid Surgery Trialists’ Collaborative Group: Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC european carotid surgery trial. Lancet 1996; 347: 1591 – 1593. Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S: Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367: 1903–1912 EAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255– 1262. Cornett O,, Ocava L, et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. Cardiol Clin 26 (2008) 251–265 Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1–13. Halkes PH, Van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367:1665-73. [Erratum, Lancet 2007;369: 274. CAPRIE Steering Committee: A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebocontrolled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-9. Amarenco P, Bogousslavsky J, Callahan A, Goldstein L, Hennerici M, Rudolph A, Sillesen H, Simunovic L, Szarek M, Welch K, Zivin J: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–559. The SPARCL Investigators. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study. Cerebrovasc Dis. 2006;21(suppl 4):1. Abstract 1. Gubitz G, Sandercock P, Counsell C: Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004: CD000024 A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting) J Am Coll Cardiol, 2007; 49:126-170, doi:10.1016/j. jacc.2006.10.021 Grysiewicz R, A, Kurian T, et al. Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors. Neurol Clin 26 (2008) 871–895 Wojner W. Hyperacute Ischemic Stroke Management: Reperfusion and EvolvingTherapies. Crit Care Nurs Clin N Am 21 (2009) 451–470 Leoo T, Lindgren B et al. Risk Factors and Treatment at Recurrent Stroke Onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis 2008;25:254–260 Jang Sung Ho. The recovery of walking in stroke patients: a review. International Journal of Rehabilitation Research 2010, 00:000–000
dc.rights.spa.fl_str_mv	Revista Ciencias Biomédicas - 2020
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Revista Ciencias Biomédicas - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Cartagena
dc.source.spa.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3091
institution	Universidad de Cartagena
bitstream.url.fl_str_mv	https://repositorio.unicartagena.edu.co/bitstreams/85c4a741-ca0d-407d-bdf6-28a796433d44/download
bitstream.checksum.fl_str_mv	6cc6c5fe507a93d4cc6e5f7305bc7b23
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Biblioteca Digital Universidad de Cartagena
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1814214216566964224
spelling	Franco Garcia, SamirBarreiro Pinto, Belis2020-12-22 00:00:002020-12-22 00:00:002020-12-222215-7840https://hdl.handle.net/11227/1335910.32997/rcb-2010-30912389-7252https://doi.org/10.32997/rcb-2010-3091application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3091/2619Núm. 2 , Año 201022522171Scott K, Chalela J, et al. Ischemic cerebrovascular disease: Clinical neurology of the Older Adult, 2nd Edition, Chapter 17. 2008Thom, T. Haase, N. Rosamond, W. et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113: 85 - 95.Finley C, Wijman, Ch. Management of acute ischemic Stroke. Neurol Clin 26 (2008) 345–371.Saposnik G, Del Brutto O. Stroke in South America. A systematic review of incidence, prevalence, and stroke subtypes. Stroke 2003; 34:2103-8.The Publications Committee for the Trial of ORG 10172 in acute Stroke treatment (TOAST) investigators: Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279:1265 – 1272Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol. 2006; 5: 323 - 331.Albers, G. Transient ischemic attack —Proposal for a new definition. N Engl J Med, 2002: 347 (21): 1713 – 1716.English, Joey. En: Harrison’s principles of internal medicine seventeenth edition, chapter 364. 2008.Guidelines for management of ischaemic Stroke and Transient ischaemic attack 2008. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovas Dis 2008; 25: 457-507.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activatorfor acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.Stroke Unit Trialists’ Collaboration: A systematic review of the randomised trials of organised impatient (stroke unit) care after stroke. BMJ 1997; 314: 1151 – 1159.IMS investigators: The Interventional Management of Stroke (IMS) II Study. Stroke 2007; 38: 2127–2135.Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339: 1415-1425.European Carotid Surgery Trialists’ Collaborative Group: Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC european carotid surgery trial. Lancet 1996; 347: 1591 – 1593.Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S: Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367: 1903–1912EAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255– 1262.Cornett O,, Ocava L, et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. Cardiol Clin 26 (2008) 251–265Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1–13.Halkes PH, Van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367:1665-73. [Erratum, Lancet 2007;369: 274.CAPRIE Steering Committee: A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339.International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebocontrolled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-9.Amarenco P, Bogousslavsky J, Callahan A, Goldstein L, Hennerici M, Rudolph A, Sillesen H, Simunovic L, Szarek M, Welch K, Zivin J: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–559.The SPARCL Investigators. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study. Cerebrovasc Dis. 2006;21(suppl 4):1. Abstract 1.Gubitz G, Sandercock P, Counsell C: Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004: CD000024A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting) J Am Coll Cardiol, 2007; 49:126-170, doi:10.1016/j. jacc.2006.10.021Grysiewicz R, A, Kurian T, et al. Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors. Neurol Clin 26 (2008) 871–895Wojner W. Hyperacute Ischemic Stroke Management: Reperfusion and EvolvingTherapies. Crit Care Nurs Clin N Am 21 (2009) 451–470Leoo T, Lindgren B et al. Risk Factors and Treatment at Recurrent Stroke Onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis 2008;25:254–260Jang Sung Ho. The recovery of walking in stroke patients: a review. International Journal of Rehabilitation Research 2010, 00:000–000Revista Ciencias Biomédicas - 2020https://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccesshttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3091Ataque. Cerebrovascular. Isquémico. Agudo. Manejo.Ataque cerebral agudo isquémicoAtaque cerebral agudo isquémicoArtículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlePublicationOREORE.xmltext/xml2438https://repositorio.unicartagena.edu.co/bitstreams/85c4a741-ca0d-407d-bdf6-28a796433d44/download6cc6c5fe507a93d4cc6e5f7305bc7b23MD5111227/13359oai:repositorio.unicartagena.edu.co:11227/133592024-09-05 15:30:47.867https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Ciencias Biomédicas - 2020metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com

Ataque cerebral agudo isquémico

Publicaciones similares